Sofosbuvir in combination with ribavirin or simeprevir: real-life study of patients with hepatitis C genotype 4

BACKGROUND: The discovery of direct-acting antiviral agents (DAA) is an outstanding achievement of modern medicine in the current century. The current study aimed to explore the effectiveness and safety of two regimens sofosbuvir (SOF) in combination with either ribavirin (RBV) or simeprevir (SMV) i...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ann Gastroenterol
Main Authors: Abdel-Moneim, Adel, Aboud, Alaa, Abdel-Gabbar, Mohamed, Zanaty, Mohamed I., Elbary, Amr A. Abd, Ramadan, Mohamed
Formato: Artigo
Idioma:Inglês
Publicado: Hellenic Society of Gastroenterology 2019
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6302204/
https://ncbi.nlm.nih.gov/pubmed/30598598
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20524/aog.2018.0327
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares